The Regard Group, The Montreux Healthcare Fund’s majority owned operating company, has acquired Adelphi Care Services in Shropshire, in a deal that will bring the capacity of the group to circa 1150 beds and adds £1.5m EBITDA to the business.

Adelphi, which has nine facilities across specialist residential and supported living services delivers a good standard of care to service users and offers significant opportunities to drive efficiencies and improve operations, supplementing an already strong portfolio with a strong presence in the area.

This acquisition adds to an already good performance from The Regard Group with 12 facilities added within the last year and 12 more planned by mid-2018 through the organic growth strategy alone. A performance recently recognised by HealthInvestor magazine who awarded the group “Specialist Care Provider of the Year”.

Oliver Harris, CEO Montreux Capital Management (UK), stated: “We believe the Adelphi Care Services acquisition will greatly benefit the group and ultimately, The Montreux Healthcare Fund’s investors. Regard’s strong growth and financial performance this year is extremely encouraging, the company has proven that driving EBITDA can be achieved whilst delivering an extremely good standard of care and this will be further evidenced in this acquisition”

Find Us

Thameside House
Hurst Road
East Molesey
KT8 9AY

T: + 44 (0) 1932 860 140
E: info@montreuxcm.com

Information on this webpage relates to and is provided by Montreux Capital Management (UK) Limited

The content of this webpage should not be construed as financial advice. Any decision to invest should be made only on the basis of the relevant documentation for each investment. Past performance is not necessarily a guide to future performance. The value of an investment may go down as well as up and investors may not get back the full amount invested. Investments in small unquoted companies carry an above-average level of risk. These investments are highly illiquid and as such, there may not be a readily available market to sell such an investment. Montreux Capital Management (UK) Limited and Sapia Partners LLP (together “the Sponsors,” or “Sponsor”) do not provide specific individual advice on the suitability of investments with regard to a potential investor’s individual circumstances, risk tolerance or investment objectives and investors should seek independent financial advice if they are in any doubt whether a product is suitable for them.

Montreux Capital Management (UK) Limited is an Appointed Representative of Sapia Partners LLP which is authorised and regulated by the Financial Conduct Authority.

ACCEPT